vs

Side-by-side financial comparison of Broadstone Net Lease, Inc. (BNL) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Vertex, Inc. is the larger business by last-quarter revenue ($196.6M vs $121.4M, roughly 1.6× Broadstone Net Lease, Inc.). Broadstone Net Lease, Inc. runs the higher net margin — 38.2% vs -1.3%, a 39.5% gap on every dollar of revenue. On growth, Broadstone Net Lease, Inc. posted the faster year-over-year revenue change (11.7% vs 11.1%). Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (10.5% CAGR vs 7.1%).

Broadstone Net Lease, Inc. is a real estate investment trust (REIT) that acquires, owns, and manages a diversified portfolio of single-tenant commercial real estate assets across the United States. Its portfolio covers key segments including industrial facilities, healthcare properties, retail locations, and office spaces, all leased to tenants under long-term net lease agreements.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

BNL vs VERX — Head-to-Head

Bigger by revenue
VERX
VERX
1.6× larger
VERX
$196.6M
$121.4M
BNL
Growing faster (revenue YoY)
BNL
BNL
+0.6% gap
BNL
11.7%
11.1%
VERX
Higher net margin
BNL
BNL
39.5% more per $
BNL
38.2%
-1.3%
VERX
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
10.5%
7.1%
BNL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BNL
BNL
VERX
VERX
Revenue
$121.4M
$196.6M
Net Profit
$46.4M
$-2.5M
Gross Margin
63.5%
Operating Margin
52.2%
31.1%
Net Margin
38.2%
-1.3%
Revenue YoY
11.7%
11.1%
Net Profit YoY
-122.6%
EPS (diluted)
$0.24
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNL
BNL
VERX
VERX
Q1 26
$121.4M
$196.6M
Q4 25
$118.3M
$194.7M
Q3 25
$114.2M
$192.1M
Q2 25
$113.0M
$184.6M
Q1 25
$108.7M
$177.1M
Q4 24
$112.1M
$178.5M
Q3 24
$108.4M
$170.4M
Q2 24
$105.9M
$161.1M
Net Profit
BNL
BNL
VERX
VERX
Q1 26
$46.4M
$-2.5M
Q4 25
$33.1M
$-7.0M
Q3 25
$26.5M
$4.0M
Q2 25
$20.2M
$-961.0K
Q1 25
$16.7M
$11.1M
Q4 24
$26.4M
$-67.8M
Q3 24
$35.6M
$7.2M
Q2 24
$35.3M
$5.2M
Gross Margin
BNL
BNL
VERX
VERX
Q1 26
63.5%
Q4 25
64.8%
Q3 25
63.1%
Q2 25
65.7%
Q1 25
63.8%
Q4 24
65.6%
Q3 24
64.8%
Q2 24
63.7%
Operating Margin
BNL
BNL
VERX
VERX
Q1 26
52.2%
31.1%
Q4 25
-1.3%
Q3 25
2.2%
Q2 25
-2.1%
Q1 25
2.5%
Q4 24
-7.3%
Q3 24
2.9%
Q2 24
4.7%
Net Margin
BNL
BNL
VERX
VERX
Q1 26
38.2%
-1.3%
Q4 25
28.0%
-3.6%
Q3 25
23.2%
2.1%
Q2 25
17.8%
-0.5%
Q1 25
15.4%
6.3%
Q4 24
23.5%
-38.0%
Q3 24
32.8%
4.2%
Q2 24
33.4%
3.2%
EPS (diluted)
BNL
BNL
VERX
VERX
Q1 26
$0.24
$-0.02
Q4 25
$0.17
Q3 25
$0.14
Q2 25
$0.10
Q1 25
$0.09
Q4 24
$0.13
Q3 24
$0.19
Q2 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNL
BNL
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$20.3M
$252.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.0B
$246.5M
Total Assets
$5.8B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNL
BNL
VERX
VERX
Q1 26
$20.3M
$252.5M
Q4 25
$30.5M
$314.0M
Q3 25
$82.0M
$313.5M
Q2 25
$20.8M
$284.4M
Q1 25
$9.6M
$270.4M
Q4 24
$14.8M
$296.1M
Q3 24
$9.0M
$279.0M
Q2 24
$18.3M
$325.5M
Total Debt
BNL
BNL
VERX
VERX
Q1 26
Q4 25
$2.5B
$337.5M
Q3 25
$2.4B
$336.9M
Q2 25
$2.1B
$336.3M
Q1 25
$2.0B
$335.8M
Q4 24
$1.9B
$335.2M
Q3 24
$2.0B
$334.7M
Q2 24
$1.9B
$334.1M
Stockholders' Equity
BNL
BNL
VERX
VERX
Q1 26
$3.0B
$246.5M
Q4 25
$2.9B
$258.9M
Q3 25
$2.9B
$264.5M
Q2 25
$2.9B
$248.0M
Q1 25
$2.9B
$200.5M
Q4 24
$3.0B
$179.4M
Q3 24
$3.0B
$259.0M
Q2 24
$3.1B
$233.1M
Total Assets
BNL
BNL
VERX
VERX
Q1 26
$5.8B
$1.2B
Q4 25
$5.7B
$1.3B
Q3 25
$5.5B
$1.2B
Q2 25
$5.3B
$1.2B
Q1 25
$5.2B
$1.2B
Q4 24
$5.2B
$1.2B
Q3 24
$5.3B
$1.2B
Q2 24
$5.3B
$1.0B
Debt / Equity
BNL
BNL
VERX
VERX
Q1 26
Q4 25
0.87×
1.30×
Q3 25
0.82×
1.27×
Q2 25
0.73×
1.36×
Q1 25
0.68×
1.67×
Q4 24
0.64×
1.87×
Q3 24
0.65×
1.29×
Q2 24
0.62×
1.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BNL
BNL
VERX
VERX
Operating Cash FlowLast quarter
$38.0M
Free Cash FlowOCF − Capex
$7.7M
FCF MarginFCF / Revenue
3.9%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BNL
BNL
VERX
VERX
Q1 26
$38.0M
Q4 25
$299.5M
$42.3M
Q3 25
$64.2M
$62.5M
Q2 25
$79.3M
$46.0M
Q1 25
$71.5M
$14.8M
Q4 24
$276.3M
$41.1M
Q3 24
$67.3M
$41.4M
Q2 24
$74.2M
$57.7M
Free Cash Flow
BNL
BNL
VERX
VERX
Q1 26
$7.7M
Q4 25
$269.8M
Q3 25
$58.0M
Q2 25
$76.7M
Q1 25
$57.1M
Q4 24
$259.5M
Q3 24
$60.3M
$-24.3M
Q2 24
$74.0M
FCF Margin
BNL
BNL
VERX
VERX
Q1 26
3.9%
Q4 25
228.1%
Q3 25
50.8%
Q2 25
67.9%
Q1 25
52.5%
Q4 24
231.4%
Q3 24
55.6%
-14.2%
Q2 24
69.9%
Capex Intensity
BNL
BNL
VERX
VERX
Q1 26
Q4 25
25.1%
Q3 25
5.4%
Q2 25
2.3%
Q1 25
13.2%
Q4 24
15.0%
Q3 24
6.5%
38.5%
Q2 24
0.2%
Cash Conversion
BNL
BNL
VERX
VERX
Q1 26
Q4 25
9.04×
Q3 25
2.43×
15.44×
Q2 25
3.93×
Q1 25
4.27×
1.33×
Q4 24
10.47×
Q3 24
1.89×
5.73×
Q2 24
2.10×
11.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BNL
BNL

Segment breakdown not available.

VERX
VERX

Software subscriptions$167.1M85%
Services$29.5M15%

Related Comparisons